ERYTECH announces the granting of its core process patent in the United States with two additional years of exclusivity

Post author:admERY
Post published:September 16, 2013
Post category:Newsroom

ERYTECH announces it received notification of allowance for the granting of its core process patent in the United States with two additional years of exclusivity in the United States.

You Might Also Like

Erytech announces trading resumption of its ordinary shares on Euronext Paris

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting

ERYTECH to Present Pre-Clinical Data at the 13th International Congress of Inborn Errors of Metabolism